Explore national- and state-level data for hundreds of health, environmental and socioeconomic measures, including background information about each measure. Use features on this page to find measures; view subpopulations, trends and rankings; and download and share content.
Oklahoma Value:
Percentage of women ages 65-74 who reported receiving a mammogram in the past two years and percentage of adults ages 65-75 who reported receiving colorectal cancer screening within the recommended time period
Oklahoma Rank:
Explore Population Data:
Appears In:
Percentage of women ages 65-74 who reported receiving a mammogram in the past two years and percentage of adults ages 65-75 who reported receiving colorectal cancer screening within the recommended time period
US Value: 74.1%
Top State(s): Connecticut, Rhode Island: 80.9%
Bottom State(s): New Mexico: 65.8%
Definition: Percentage of women ages 65-74 who reported receiving a mammogram in the past two years and percentage of adults ages 65-75 who reported receiving colorectal cancer screening within the recommended time period
Data Source and Years(s): CDC, Behavioral Risk Factor Surveillance System, 2022
Suggested Citation: America's Health Rankings analysis of CDC, Behavioral Risk Factor Surveillance System, United Health Foundation, AmericasHealthRankings.org, accessed 2024.
Cancer has been one of the top two leading causes of death in the United States for over 75 years. Cancer screenings may detect cancer early, when treatment is easiest and most effective. Mammography and colorectal cancer screenings have saved many lives and are important methods for preventing breast and colorectal cancer deaths. Both mammography and colorectal screening are cost-effective compared with no screening.
Despite their effectiveness in preventing cancers, mammography and colorectal cancer screening rates remain below national targets, and in the spring of 2020 screening rates declined sharply because of the COVID-19 pandemic. Factors that may affect cancer screening behavior include screening costs, health insurance status, access to health care facilities and sociodemographic differences.
According to America’s Health Rankings analysis, the prevalence of receiving the recommended number of breast and colorectal cancer screenings is higher among:
The United States Preventive Services Task Force recommends women older than the age of 40 receive a breast cancer screening mammogram every two years. Current evidence is insufficient to assess if the benefits of mammography outweigh the harms for women age 75 and older. Routine colorectal cancer screening is also recommended for all adults ages 50-75; for adults older than 75, it is an individual choice to be discussed with a doctor.
The Community Guide assesses evidence-based community-level interventions to increase cancer screening, such as patient reminders and one-on-one education. The Return-to-Screening quality improvement project and clinical study has shown significant increases in cancer screening volume at hospitals recovering from the impact of the COVID-19 pandemic.
The Centers for Disease Control and Prevention recommends interventions that simplify the health care navigation process and expand accessibility and availability of care to address structural barriers. Evidence-based approaches include:
Healthy People 2030 has several objectives regarding cancer screenings, including:
“Cancer Facts & Figures 2021.” Atlanta, GA: American Cancer Society, 2021. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2021/cancer-facts-and-figures-2021.pdf.
Chen, Ronald C., Kevin Haynes, Simo Du, John Barron, and Aaron J. Katz. “Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.” JAMA Oncology 7, no. 6 (June 1, 2021): 878. https://doi.org/10.1001/jamaoncol.2021.0884.
Jayasekera, Jinani, and Jeanne S. Mandelblatt. “Systematic Review of the Cost Effectiveness of Breast Cancer Prevention, Screening, and Treatment Interventions.” Journal of Clinical Oncology 38, no. 4 (February 1, 2020): 332–50. https://doi.org/10.1200/JCO.19.01525.
Joung, Rachel Hae-Soo, Timothy W. Mullett, Scott H. Kurtzman, Sarah Shafir, James B. Harris, Katharine A. Yao, Karl Y. Bilimoria, et al. “Evaluation of a National Quality Improvement Collaborative for Improving Cancer Screening.” JAMA Network Open 5, no. 11 (November 16, 2022): e2242354. https://doi.org/10.1001/jamanetworkopen.2022.42354.
Khalili, Farhad, Behzad Najafi, Fariborz Mansour-Ghanaei, Mahmood Yousefi, Hadi Abdollahzad, and Ali Motlagh. “Cost-Effectiveness Analysis of Colorectal Cancer Screening: A Systematic Review.” Risk Management and Healthcare Policy Volume 13 (September 2020): 1499–1512. https://doi.org/10.2147/RMHP.S262171.
Ma, Zhen-Qiang, and Lisa C. Richardson. “Cancer Screening Prevalence and Associated Factors Among US Adults.” Preventing Chronic Disease 19 (April 21, 2022): 220063. https://doi.org/10.5888/pcd19.220063.
America’s Health Rankings builds on the work of the United Health Foundation to draw attention to public health and better understand the health of various populations. Our platform provides relevant information that policymakers, public health officials, advocates and leaders can use to effect change in their communities.
We have developed detailed analyses on the health of key populations in the country, including women and children, seniors and those who have served in the U.S. Armed Forces, in addition to a deep dive into health disparities across the country.